Delirium in the pediatric hematology, oncology, and bone marrow transplant population

Katrina Winsnes, Paul Sochacki, Carl Eriksson, Evan Shereck, Michael Recht, Kyle Johnson, Rebecca Loret De Mola, Linda Stork

Research output: Contribution to journalArticle

Abstract

Background: Delirium affects 10% to 30% of patients in pediatric intensive care units (PICU) and is associated with increased length of stay and prolonged late sequela. There are no prospective trials evaluating delirium in the pediatric hematology, oncology, and bone marrow transplant (PHO) population. Hypothesizing that delirium is underrecognized in this population, our study aimed to identify the prevalence of delirium in hospitalized PHO patients and associated risk factors. Procedure: PHO and PICU nurses were trained to use the Cornell Assessment for Pediatric Delirium and to record scores once every 12-hour shift. Predetermined demographic and clinical variables were collected daily on all hospitalized PHO patients during the year-long prospective study. Results: Prior to initiating routine delirium screening, 1.1% of PHO admissions and 2.4% of unique patients had delirium mentioned in a progress note. This study included 807 consecutive admissions: 671 oncology, 49 hematology, and 87 bone marrow transplant (BMT) hospitalizations among 223 unique PHO patients. The prevalence of delirium among hospitalizations was 5% and among unique patients was 13%. Among BMT hospitalizations, the prevalence was 23%. Multiple logistic regression identified significant association of delirium with increased length of stay, admission to the BMT service, patient location (PICU vs PHO unit), benzodiazepine, opioid, and anticholinergic administration. Conclusions: Before routine screening, delirium was underrecognized in this PHO-hospitalized population. Patients at highest risk had prolonged hospital stays, PICU admissions, BMT, and/or frequent use of benzodiazepines, opioids, or anticholinergics. Routine screening is feasible and may improve our recognition of delirium.

Original languageEnglish (US)
Article numbere27640
JournalPediatric Blood and Cancer
DOIs
StatePublished - Jan 1 2019

Fingerprint

Delirium
Hematology
Bone Marrow
Pediatrics
Transplants
Population
Pediatric Intensive Care Units
Length of Stay
Hospitalization
Cholinergic Antagonists
Benzodiazepines
Opioid Analgesics
Logistic Models
Nurses
Demography
Prospective Studies

Keywords

  • delirium
  • outcomes research
  • pediatric hematology/oncology
  • transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Delirium in the pediatric hematology, oncology, and bone marrow transplant population. / Winsnes, Katrina; Sochacki, Paul; Eriksson, Carl; Shereck, Evan; Recht, Michael; Johnson, Kyle; Loret De Mola, Rebecca; Stork, Linda.

In: Pediatric Blood and Cancer, 01.01.2019.

Research output: Contribution to journalArticle

@article{224b1745e0f5470899e6337e1b6bedce,
title = "Delirium in the pediatric hematology, oncology, and bone marrow transplant population",
abstract = "Background: Delirium affects 10{\%} to 30{\%} of patients in pediatric intensive care units (PICU) and is associated with increased length of stay and prolonged late sequela. There are no prospective trials evaluating delirium in the pediatric hematology, oncology, and bone marrow transplant (PHO) population. Hypothesizing that delirium is underrecognized in this population, our study aimed to identify the prevalence of delirium in hospitalized PHO patients and associated risk factors. Procedure: PHO and PICU nurses were trained to use the Cornell Assessment for Pediatric Delirium and to record scores once every 12-hour shift. Predetermined demographic and clinical variables were collected daily on all hospitalized PHO patients during the year-long prospective study. Results: Prior to initiating routine delirium screening, 1.1{\%} of PHO admissions and 2.4{\%} of unique patients had delirium mentioned in a progress note. This study included 807 consecutive admissions: 671 oncology, 49 hematology, and 87 bone marrow transplant (BMT) hospitalizations among 223 unique PHO patients. The prevalence of delirium among hospitalizations was 5{\%} and among unique patients was 13{\%}. Among BMT hospitalizations, the prevalence was 23{\%}. Multiple logistic regression identified significant association of delirium with increased length of stay, admission to the BMT service, patient location (PICU vs PHO unit), benzodiazepine, opioid, and anticholinergic administration. Conclusions: Before routine screening, delirium was underrecognized in this PHO-hospitalized population. Patients at highest risk had prolonged hospital stays, PICU admissions, BMT, and/or frequent use of benzodiazepines, opioids, or anticholinergics. Routine screening is feasible and may improve our recognition of delirium.",
keywords = "delirium, outcomes research, pediatric hematology/oncology, transplantation",
author = "Katrina Winsnes and Paul Sochacki and Carl Eriksson and Evan Shereck and Michael Recht and Kyle Johnson and {Loret De Mola}, Rebecca and Linda Stork",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/pbc.27640",
language = "English (US)",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Delirium in the pediatric hematology, oncology, and bone marrow transplant population

AU - Winsnes, Katrina

AU - Sochacki, Paul

AU - Eriksson, Carl

AU - Shereck, Evan

AU - Recht, Michael

AU - Johnson, Kyle

AU - Loret De Mola, Rebecca

AU - Stork, Linda

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Delirium affects 10% to 30% of patients in pediatric intensive care units (PICU) and is associated with increased length of stay and prolonged late sequela. There are no prospective trials evaluating delirium in the pediatric hematology, oncology, and bone marrow transplant (PHO) population. Hypothesizing that delirium is underrecognized in this population, our study aimed to identify the prevalence of delirium in hospitalized PHO patients and associated risk factors. Procedure: PHO and PICU nurses were trained to use the Cornell Assessment for Pediatric Delirium and to record scores once every 12-hour shift. Predetermined demographic and clinical variables were collected daily on all hospitalized PHO patients during the year-long prospective study. Results: Prior to initiating routine delirium screening, 1.1% of PHO admissions and 2.4% of unique patients had delirium mentioned in a progress note. This study included 807 consecutive admissions: 671 oncology, 49 hematology, and 87 bone marrow transplant (BMT) hospitalizations among 223 unique PHO patients. The prevalence of delirium among hospitalizations was 5% and among unique patients was 13%. Among BMT hospitalizations, the prevalence was 23%. Multiple logistic regression identified significant association of delirium with increased length of stay, admission to the BMT service, patient location (PICU vs PHO unit), benzodiazepine, opioid, and anticholinergic administration. Conclusions: Before routine screening, delirium was underrecognized in this PHO-hospitalized population. Patients at highest risk had prolonged hospital stays, PICU admissions, BMT, and/or frequent use of benzodiazepines, opioids, or anticholinergics. Routine screening is feasible and may improve our recognition of delirium.

AB - Background: Delirium affects 10% to 30% of patients in pediatric intensive care units (PICU) and is associated with increased length of stay and prolonged late sequela. There are no prospective trials evaluating delirium in the pediatric hematology, oncology, and bone marrow transplant (PHO) population. Hypothesizing that delirium is underrecognized in this population, our study aimed to identify the prevalence of delirium in hospitalized PHO patients and associated risk factors. Procedure: PHO and PICU nurses were trained to use the Cornell Assessment for Pediatric Delirium and to record scores once every 12-hour shift. Predetermined demographic and clinical variables were collected daily on all hospitalized PHO patients during the year-long prospective study. Results: Prior to initiating routine delirium screening, 1.1% of PHO admissions and 2.4% of unique patients had delirium mentioned in a progress note. This study included 807 consecutive admissions: 671 oncology, 49 hematology, and 87 bone marrow transplant (BMT) hospitalizations among 223 unique PHO patients. The prevalence of delirium among hospitalizations was 5% and among unique patients was 13%. Among BMT hospitalizations, the prevalence was 23%. Multiple logistic regression identified significant association of delirium with increased length of stay, admission to the BMT service, patient location (PICU vs PHO unit), benzodiazepine, opioid, and anticholinergic administration. Conclusions: Before routine screening, delirium was underrecognized in this PHO-hospitalized population. Patients at highest risk had prolonged hospital stays, PICU admissions, BMT, and/or frequent use of benzodiazepines, opioids, or anticholinergics. Routine screening is feasible and may improve our recognition of delirium.

KW - delirium

KW - outcomes research

KW - pediatric hematology/oncology

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=85060810072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060810072&partnerID=8YFLogxK

U2 - 10.1002/pbc.27640

DO - 10.1002/pbc.27640

M3 - Article

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

M1 - e27640

ER -